SNSE – sensei biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
Form 144 Sensei Biotherapeutics, Filed by: Cambrian BioPharma Inc
Form 144 Sensei Biotherapeutics, Filed by: Cambrian BioPharma Inc
Form 3 Sensei Biotherapeutics, For: Nov 14 Filed by: Gerry Christopher
Form 10-Q Sensei Biotherapeutics, For: Sep 30
Form 8-K Sensei Biotherapeutics, For: Nov 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.